{"id":4300,"date":"2017-08-12T11:10:18","date_gmt":"2017-08-12T11:10:18","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/2017\/08\/12\/clinical-and-translational-oncology-feasibility-of-a-deep-hyperthermia-and-radiotherapy-programme-for-advanced-tumors-first-spanish-experience\/"},"modified":"2025-09-03T13:51:23","modified_gmt":"2025-09-03T13:51:23","slug":"klinicno-preskusanje-hipertermije","status":"publish","type":"post","link":"https:\/\/andromedichyperthermia.com\/sl\/klinicno-preskusanje-hipertermije\/","title":{"rendered":"Klini\u010dno presku\u0161anje: Predhodni rezultati kemoradiacije s hipertermijo in brahiterapije z visokim odmerkom za lokalno napredovali karcinom materni\u010dnega vratu"},"content":{"rendered":"<div><\/div>\n<div class=\"clinical_trial\">\n<h1 style=\"text-align: center;\"><a href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/POSTER-HT-ESHO-2014-clarke.pdf\"><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">Klini\u010dno presku\u0161anje: Predhodni rezultati kemoradiacije s hipertermijo in brahiterapije z visokim odmerkom za lokalno napredovali karcinom materni\u010dnega vratu<\/span><\/span><\/a><\/h1>\n<h2 style=\"text-align: center;\"><a href=\"https:\/\/www.esho.info\/\" target=\"_blank\" rel=\"noopener\"><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">Klini\u010dno presku\u0161anje Andromedic hipertermije &#8211; kongres Evropskega zdru\u017eenja za hipertermi\u010dno onkologijo 2014\u00a0<\/span><\/span><\/a><\/h2>\n<h2 style=\"text-align: center;\"><\/h2>\n<figure id=\"attachment_114\" aria-describedby=\"caption-attachment-114\" style=\"width: 590px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-114 size-full\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" alt=\"klini\u010dno presku\u0161anje - predhodni rezultati kemoradiacije z andromedno hipertermijo in brahiterapijo z visokim odmerkom za lokalno napredovali karcinom materni\u010dnega vratu\" width=\"590\" height=\"837\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" \/><figcaption id=\"caption-attachment-114\" class=\"wp-caption-text\"><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">Predhodni rezultati kemoradiacije z andromedno hipertermijo in brahiterapijo z visokim odmerkom za lokalno napredovali karcinom materni\u010dnega vratu<\/span><\/span><\/figcaption><\/figure>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">E. Clarke, V. De Sanctis, C. Scaringi, M. Valeriani, MF Osti, Bolni\u0161nica R. Maurizi Enrici Sant&#8217;Andrea, Oddelek za radioterapijo, Univerza v Rimu &#8216;Sapienza&#8217;, Rim, Italija<\/span><\/span><\/p>\n<p><strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">CILJI<\/span><\/span><\/strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\"> Raziskati izid kemoradioterapije s hipertermijo (HT) in brahiterapije z visokim odmerkom (BRT) pri lokalno napredovalem karcinomu materni\u010dnega vratu (LACC). Ali se kemoradioterapija \u0161teje za standardno zdravljenje pri LACC? Dodatek HT k radioterapiji (RT) sam po sebi izbolj\u0161a lokalni nadzor tumorja in celokupno pre\u017eivetje, ne da bi pri tem vplival na z zdravljenjem povezano akutno ali pozno toksi\u010dnost 3. do 4. stopnje pri tej skupini bolnic.<\/span><\/span><\/p>\n<p><strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">MATERIALI IN METODE<\/span><\/span><\/strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\"> Od januarja 2013 do decembra 2013 je bilo v pilotno \u0161tudijo, ki je kombinirala tedenski cisplatin in hormonsko terapijo (HT) z radioterapijo z modulirano intenzivnostjo (IMRT), ki ji je sledila BRT, vklju\u010denih 8 bolnic z LACC ali lokalno recidivnim karcinomom materni\u010dnega vratu (LRCC) po histerektomiji (3 stadiji IIB, I IIIB, 2 NEI in 3 LRCC). Hkratna kemoterapija je v 5,5 tednih v medeni\u010dne bezgavke dala odmerek 50,4 Gy s so\u010dasnim integriranim pove\u010danjem (SIB) bruto volumna tumorja (GTV) do skupno 61,8 Gy v 28 frakcijah. Odmerek BRT je bil 21 Gy v 3 frakcijah. So\u010dasni kemoterapevtski re\u017eim je obsegal tedenski cisplatin 4\/mg\/m2 in HT enkrat na teden.<\/span><\/span><\/p>\n<p><strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">REZULTATI Vsi bolniki so dosegli lokalni nadzor. Pri enem bolniku se je pojavila ponovitev zunaj medenice z ve\u010d kostmi in paraaortnimi bezgavkami. Z zdravljenjem povezane akutne ali pozne toksi\u010dnosti 3. do 4. stopnje niso opazili.<\/span><\/span><\/strong><\/p>\n<p><strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">ZAKLJU\u010cKI Ta re\u017eim je bil dobro prena\u0161an, klini\u010dni odziv pa je bil dober. Dodatek HT h kemoradioterapiji predstavlja obetavno novo strategijo.<\/span><\/span><\/strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\"> Za potrditev njene u\u010dinkovitosti so potrebna ve\u010dinstitucionalna sodelovanja in dalj\u0161e spremljanje.<\/span><\/span><\/p>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">BIBLIOGRAFIJA<\/span><\/span><\/p>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">1. Lutgens L. van der Zee J. Pijls-Johannesma M, De Haas-Kock DF, Buijsen J. Mastrigt GA. Lammering G. De Ruysscher DK. Lambin R Kombinirana uporaba hipertermije in radioterapije za zdravljenje lokalno napredovalega karcinoma materni\u010dnega vratu. Cochrane Database Syst Rev. 17. marec 2010:(3):CD008377. doi:10.1002\/14851858.CD006377.pub3.<\/span><\/span><\/p>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">2. van der Zee J. Gonzalez Gonzalez D. van Rhoon GC, van Dijk JD. van Pullen WL, Hart AA. Primerjava same radioterapije z radioterapijo in hipertermijo pri lokalno napredovalih medeni\u010dnih tumorjih: prospektivna, randomizirana, multicentri\u010dna \u0161tudija. Nizozemska skupina za globoko hipertermijo. Lancet. 1. april 2000: 355(9210): 1119-25.<\/span><\/span><\/p>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">3. Green J, Kirwan .1, Tremey J. Vale C. Symonds R Fresco L. Williams C. Collingwood M. So\u010dasna kemoterapija in radioterapija za raka materni\u010dnega vratu. Cochrane Database Syst Rev. 20. julij 2005;(3):C0002225.<\/span><\/span><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Klini\u010dno presku\u0161anje: Predhodni rezultati kemoradiacije s hipertermijo in brahiterapije z visokim odmerkom za lokalno napredovali karcinom materni\u010dnega vratu Klini\u010dno presku\u0161anje Andromedic hipertermije &#8211; kongres Evropskega zdru\u017eenja za hipertermi\u010dno onkologijo 2014\u00a0 E. Clarke, V. De Sanctis, C. Scaringi, M. Valeriani, MF Osti, Bolni\u0161nica R. Maurizi Enrici Sant&#8217;Andrea, Oddelek za radioterapijo, Univerza v Rimu &#8216;Sapienza&#8217;, Rim, Italija&hellip;<\/p>\n","protected":false},"author":1,"featured_media":7029,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[217,772,218,219,220,221],"class_list":["post-4300","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-sl","tag-advanced-tumors-sl","tag-hipertermija-sl","tag-hyperthermia-sl","tag-local-hyperthermia-sl","tag-meht-sl","tag-radiotherapy-sl"],"gutentor_comment":0,"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/posts\/4300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/comments?post=4300"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/posts\/4300\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/media\/7029"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/media?parent=4300"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/categories?post=4300"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sl\/wp-json\/wp\/v2\/tags?post=4300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}